欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0306/001
药品名称
EURICAN DAPPI
活性成分
canine adenovirus 0.0 CCID50
canine distemper virus 0.0 CCID50
canine parainfluenza virus 0.0 CCID50
canine parvovirus 0.0 CCID50
剂型
Lyophilisate and solvent for suspension for injection
上市许可持有人
MERIAL
参考成员国 - 产品名称
France (FR)
EURICAN DAPPI
互认成员国 - 产品名称
Finland (FI)
Croatia (HR)
Malta (MT)
Slovenia (SI)
Slovakia (SK)
Romania (RO)
Czechia (CZ)
EURICAN DAPPi lyofilizát a rozpouštědlo pro injekční suspenzi
Cyprus (CY)
Bulgaria (BG)
Hungary (HU)
Eurican DHPPi2 vakcina A.U.V.
Estonia (EE)
Lithuania (LT)
Latvia (LV)
Eurican DAPPi
Poland (PL)
Norway (NO)
Sweden (SE)
Greece (GR)
Italy (IT)
Portugal (PT)
Spain (ES)
Austria (AT)
Eurican DAPPi Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Ireland (IE)
United Kingdom (Northern Ireland) (XI)
EURICAN CHPPi2
Luxembourg (LU)
Netherlands (NL)
Belgium (BE)
Eurican DAPPi
Denmark (DK)
Eurican DAPPi
Germany (DE)
Eurican DAPPi
许可日期
2016/02/24
最近更新日期
2024/04/24
药物ATC编码
QI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Full dossier - art 12.3 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PAR
|
11319 EURICAN DAPPi_ PuAR feb2024
Date of last change:2024/02/05
Final Product Information
|
11319_eurican_dappi_clean_20240201
Date of last change:2024/02/01
PAR
|
EURICAN DAPPi- PuAR nov2016
Date of last change:2016/11/18
Final SPC
|
Eurican DAPPi - SPC D90
Date of last change:2016/09/27
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase